A ceramide way to treat Non-alcoholic fatty liver disease (NAFLD): α-galactosylceramide promotes degradation of HMGCR, decreases the levels of triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD via down regulation of its target gene, 3/June/2018, 11.18 pm